Investors
Information Disclosure
-
VOLUNTARY ANNOUNCEMENT - PURCHASE OF SHARES BY CHIA TAI TIANQING UNDER THE SHARE INCENTIVE SCHEME2024.10.21
-
VOLUNTARY ANNOUNCEMENT - PURCHASE OF SHARES BY CHIA TAI TIANQING UNDER THE SHARE INCENTIVE SCHEME2024.10.09
-
VOLUNTARY ANNOUNCEMENT - SIGNING OF AN EXCLUSIVE LICENSE AND COOPERATION AGREEMENT WITH YZY BIOPHARMA2024.10.08
-
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME2024.10.07
-
VOLUNTARY ANNOUNCEMENT - PROGRESS UPDATE ON THE "IMPLEMENTATION OF SHARE INCENTIVE SCHEME BY CHIA TAI TIANQING"2024.10.04
-
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME2024.10.03
-
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 SEPTEMBER 20242024.10.02
-
VOLUNTARY ANNOUNCEMENT - PHASE III STUDY RESULTS OF CULMERCICLIB IN COMBINATION WITH FULVESTRANT FOR TREATMENT OF HR+/HER2- ADVANCED BREAST CANCER FOLLOWING ENDOCRINE TREATMENT PRESENTED AT 2024 CSCO2024.09.27